Mi SciELO
Servicios Personalizados
Articulo
Indicadores
Citado por SciELO
Links relacionados
Similares en SciELO
Compartir
Revista Finlay
versión On-line ISSN 2221-2434
Resumen
CANETE FONSECA, Mahité; FUENTES DIAZ, Zaily y RODRIGUEZ SALAZAR, Orlando. Behavior of Anemia due to Toxicity to Chemotherapy in Patients with Lung Cancer. Rev. Finlay [online]. 2023, vol.13, n.3, pp. 314-319. Epub 30-Sep-2023. ISSN 2221-2434.
Foundation:
anemia constitutes one of the most frequent toxicities with intrinsic risk factors in the patient. Anemia due to toxicity due to chemotherapy is considered a single-line hematopoietic dysfunction of iatrogenic cause due to its relationship to treatment.
Objective:
to characterize the behavior of anemia due to toxicity to chemotherapy in patients with lung cancer.
Method:
a descriptive and retrospective study was carried out in patients with lung cancer who received chemotherapy treatment at the María Curie Provincial Teaching Oncology Hospital in Camagüey province, from January 2020 to December 2022. The population under study the study consisted of 101 patients who met the inclusion criteria. The variables studied were: age, sex, staging, condition at discharge and anemia due to toxicity. Documentary analysis was used as a method, through the review of medical records.
Results:
the male sex predominated with 73.3 % of the cases of lung cancer, there were no differences in terms of age according to sex. Most of the patients were found in stages IIIA 36.6 % and IIIB 33.6 %. 56.4 % were discharged alive and 21.8 % of the patients who received chemotherapy developed anemia due to toxicity.
Conclusions:
the male sex predominated, most of the patients were in stages IIIA and IIIB, the highest percentage of patients were discharged alive and a considerable number of those who received chemotherapy developed anemia due to toxicity.
Palabras clave : carcinoma lung; drug therapy combination; neoplasms; mortality; incidence; cuba.